P.A.W. Capital’s Xtant Medical Holdings XTNT Stock Holding History

P.A.W. Capital’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50.5K	Buy	+120,000	New	+$57.6K	0.02%	88

Other funds holding XTNT

Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

AIC

AWM Investment Company New York $1.04B AUM 103.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.18B AUM 13.12% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $140M AUM 44.76% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

P.A.W. Capital's XTNT Position: Q2 2026 in Review

P.A.W. Capital opened a new position in Xtant Medical Holdings (XTNT) in Q2 2026: 120,000 shares worth $50.5K. The stake represents 0.02% of the portfolio and ranks #88 among its holdings.

33 funds tracked by Wall St. Rank hold XTNT as of Q2 2026.

P.A.W. Capital held 120,000 shares of Xtant Medical Holdings worth $50.5K as of Q2 2026.
Xtant Medical Holdings was a new P.A.W. Capital position in Q2 2026.
Xtant Medical Holdings made up 0.02% of P.A.W. Capital's portfolio in Q2 2026, its #88 holding.
33 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2026.

Based on P.A.W. Capital's 13F filing for Q2 2026, filed 28 Jul 2026.